149 related articles for article (PubMed ID: 15635615)
1. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 levels in children with cystic fibrosis.
Ademhan Tural D; Emiralioglu N; Akin S; Alboga D; Ozsezen B; Nayir Buyuksahin H; Guzelkas I; Kasikci M; Sunman B; Gungor I; Yalcin E; Dogru D; Kiper N; Demirel AH; Ozcelik U
Eur J Pediatr; 2024 May; 183(5):2333-2342. PubMed ID: 38430280
[TBL] [Abstract][Full Text] [Related]
3. Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis.
Sagel SD; Wagner BD; Anthony MM; Emmett P; Zemanick ET
Am J Respir Crit Care Med; 2012 Nov; 186(9):857-65. PubMed ID: 22904182
[TBL] [Abstract][Full Text] [Related]
4. Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy.
Müller U; Hentschel J; Janhsen WK; Hünniger K; Hipler UC; Sonnemann J; Pfister W; Böer K; Lehmann T; Mainz JG
Mediators Inflamm; 2015; 2015():626530. PubMed ID: 26185365
[TBL] [Abstract][Full Text] [Related]
5. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis.
Eickmeier O; Fussbroich D; Mueller K; Serve F; Smaczny C; Zielen S; Schubert R
PLoS One; 2017; 12(2):e0171249. PubMed ID: 28158236
[TBL] [Abstract][Full Text] [Related]
6. Lung inflammation biomarkers and lung function in children chronically exposed to arsenic.
Olivas-Calderón E; Recio-Vega R; Gandolfi AJ; Lantz RC; González-Cortes T; Gonzalez-De Alba C; Froines JR; Espinosa-Fematt JA
Toxicol Appl Pharmacol; 2015 Sep; 287(2):161-167. PubMed ID: 26048584
[TBL] [Abstract][Full Text] [Related]
7. Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
Guyot N; Butler MW; McNally P; Weldon S; Greene CM; Levine RL; O'Neill SJ; Taggart CC; McElvaney NG
J Biol Chem; 2008 Nov; 283(47):32377-85. PubMed ID: 18799464
[TBL] [Abstract][Full Text] [Related]
8. SPLUNC1 as a biomarker of pulmonary exacerbations in children with cystic fibrosis.
Ben-Meir E; Perrem L; Shaw M; Ratjen F; Grasemann H
J Cyst Fibros; 2024 Mar; 23(2):288-292. PubMed ID: 38413298
[TBL] [Abstract][Full Text] [Related]
9. Airway Inflammation in Children with Primary Ciliary Dyskinesia.
Sagel SD; Kupfer O; Wagner BD; Davis SD; Dell SD; Ferkol TW; Hoppe JE; Rosenfeld M; Sullivan KM; Tiddens HAWM; Knowles MR; Leigh MW
Ann Am Thorac Soc; 2023 Jan; 20(1):67-74. PubMed ID: 35984413
[No Abstract] [Full Text] [Related]
10. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling.
Lanone S; Zheng T; Zhu Z; Liu W; Lee CG; Ma B; Chen Q; Homer RJ; Wang J; Rabach LA; Rabach ME; Shipley JM; Shapiro SD; Senior RM; Elias JA
J Clin Invest; 2002 Aug; 110(4):463-74. PubMed ID: 12189240
[TBL] [Abstract][Full Text] [Related]
11. Changes and clinical significance of serum MMP-9, TIMP-1, COX-2, and immune levels in patients with asthma.
Ming H; Huang Y; Mao J; Wang H; Gao X; Li Z
Allergol Immunopathol (Madr); 2023; 51(6):83-88. PubMed ID: 37937500
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.
Vasu VT; de Cruz SJ; Houghton JS; Hayakawa KA; Morrissey BM; Cross CE; Eiserich JP
Free Radic Res; 2011 Feb; 45(2):165-76. PubMed ID: 20954832
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease.
Wagner CJ; Schultz C; Mall MA
Mol Cell Pediatr; 2016 Dec; 3(1):25. PubMed ID: 27456476
[TBL] [Abstract][Full Text] [Related]
14. Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis.
Nie S; Zhang H; Mayer KM; Oppenheim FG; Little FF; Greenberg J; Uluer AZ; Walt DR
PLoS One; 2015; 10(8):e0135237. PubMed ID: 26258476
[TBL] [Abstract][Full Text] [Related]
15. Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations.
Houston CJ; Alkhatib A; Einarsson GG; Tunney MM; Taggart CC; Downey DG
Eur Respir J; 2024 Feb; 63(2):. PubMed ID: 38135443
[TBL] [Abstract][Full Text] [Related]
16. Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.
Griese M; Essl R; Schmidt R; Ballmann M; Paul K; Rietschel E; Ratjen F;
Respir Res; 2005 Nov; 6(1):133. PubMed ID: 16274485
[TBL] [Abstract][Full Text] [Related]
17. A Flow Cytometric Method for Isolating Cystic Fibrosis Airway Macrophages from Expectorated Sputum.
Hisert KB; Liles WC; Manicone AM
Am J Respir Cell Mol Biol; 2019 Jul; 61(1):42-50. PubMed ID: 30742539
[TBL] [Abstract][Full Text] [Related]
18. Sputum from People with Cystic Fibrosis Reduces the Killing of Methicillin-Resistant
Fantone KM; Goldberg JB; Stecenko AA; Rada B
Pathogens; 2023 Sep; 12(9):. PubMed ID: 37764956
[TBL] [Abstract][Full Text] [Related]
19. Sputum biomarkers of inflammation in cystic fibrosis lung disease.
Sagel SD; Chmiel JF; Konstan MW
Proc Am Thorac Soc; 2007 Aug; 4(4):406-17. PubMed ID: 17652508
[TBL] [Abstract][Full Text] [Related]
20. Association of low-density neutrophils with lung function and disease progression in adult cystic fibrosis.
Murru A; Vadeboncoeur N; Therrien AA; Coderre L; Vaillancourt M; Labrecque MM; Berthiaume Y; Bouvet G; Adam D; Brochiero E; Lesage S; Flamand N; Bilodeau L; Fernandes MJ
J Cyst Fibros; 2023 Nov; 22(6):1080-1084. PubMed ID: 36973151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
